{"id":13733,"date":"2020-06-24T10:50:44","date_gmt":"2020-06-24T10:50:44","guid":{"rendered":"https:\/\/qubyx.com\/qubyx-beneficie-de-lautorisation-fda-510-k-pour-un-pack-logiciel-perfectlum-4-0-et-apple-5k-imac\/"},"modified":"2020-06-24T10:50:44","modified_gmt":"2020-06-24T10:50:44","slug":"qubyx-beneficie-de-lautorisation-fda-510-k-pour-un-pack-logiciel-perfectlum-4-0-et-apple-5k-imac","status":"publish","type":"post","link":"https:\/\/qubyx.com\/fr\/qubyx-beneficie-de-lautorisation-fda-510-k-pour-un-pack-logiciel-perfectlum-4-0-et-apple-5k-imac\/","title":{"rendered":"QUBYX b\u00e9n\u00e9ficie de l\u2019autorisation FDA 510 (k) pour un pack logiciel PerfectLum 4.0 et Apple 5K iMac."},"content":{"rendered":"<p><em>Wilmington, DE, \u00c9tats-Unis, 24 juin 2020<\/em><\/p>\n<h1>QUBYX Medical Solutions Inc. a annonc\u00e9 l\u2019autorisation FDA 510(k) pour regrouper QUBYX PerfectLum avec l\u2019Apple iMac 27&Prime; pour une mise \u00e0 niveau de dispositif m\u00e9dical.<\/h1>\n<p>Avec cette initiative, QUBYX renforce sa pr\u00e9sence sur le march\u00e9 important du diagnostic, de la t\u00e9l\u00e9radiologie et des \u00e9crans m\u00e9dicaux avec un produit qui risque de sous-estimer la plupart des moniteurs m\u00e9dicaux approuv\u00e9s par la FDA. C\u2019est le premier \u00e9cran m\u00e9dical diagnostique Apple iMac propos\u00e9 aux \u00e9tablissements de sant\u00e9. <\/p>\n<p>Le PerfectLum de QUBYX est un syst\u00e8me de calibration multi-plateforme, multilingue, complet et dot\u00e9 de gestion \u00e0 distance, qui am\u00e9liore consid\u00e9rablement les performances d\u2019affichage dans toutes les circonstances. Plus important encore, PerfectLum offre une conformit\u00e9 \u00e0 jour sp\u00e9cifique \u00e0 l\u2019industrie en mati\u00e8re d\u2019imagerie m\u00e9dicale <\/p>\n<p>(y compris NEMA DICOM partie 14 GSDF). C\u2019est la premi\u00e8re fois que de telles normes sp\u00e9cifiques \u00e0 l\u2019industrie sont r\u00e9alisables sur un Mac. <\/p>\n<p>Apple a une longue histoire de moniteurs de performance haut de gamme et les mod\u00e8les actuels ne font pas exception, offrant des sp\u00e9cifications impressionnantes \u2013 500 nits de luminosit\u00e9, 5K avec r\u00e9solution 5120 x 2880, P3 (couleur large) et un milliard de couleurs.<\/p>\n<p>PerfectLum de QUBYX est un outil multiplateforme, multilingue, complet et dot\u00e9 d\u2019une solution de gestion \u00e0 distance et de cloud, qui non seulement calibre un \u00e9cran m\u00e9dical primaire ou secondaire, mais effectue \u00e9galement des tests d\u2019acceptation et de constance pour v\u00e9rifier que les \u00e9crans respectent syst\u00e9matiquement des r\u00e9glementations internationales telles que : NEMA DICOM partie 14, GSDF, AAPM TG-18, DIN 6868-57, DIN 6868-157,  JESRA X-0093, IEC 62563-1 ACR et directives NYS\/NYC Primary Diagnostic Monitor (NY PDM).<\/p>\n<p>La PerfectLum Suite est la solution privil\u00e9gi\u00e9e d\u2019\u00e9talonnage et de contr\u00f4le qualit\u00e9 des \u00e9crans m\u00e9dicaux utilis\u00e9e par les h\u00f4pitaux, les entreprises de t\u00e9l\u00e9radiologie, les services de sant\u00e9 universitaires et d\u2019autres \u00e9tablissements m\u00e9dicaux dans le monde entier. L\u2019int\u00e9gration de PerfectLum avec l\u2019iMac Apple 5K 27&Prime;, cr\u00e9e un duo parfait. En savoir plus sur PerfectLum  <\/p>\n<h4>Marc Leppla, CTO chez QUBYX, a d\u00e9clar\u00e9 :<\/h4>\n<p>\u00ab QUBYX d\u00e9montre une fois de plus sa capacit\u00e9 \u00e0 am\u00e9liorer significativement les performances des \u00e9crans dans tous les environnements, y compris les moniteurs m\u00e9dicaux, les ordinateurs portables et les \u00e9crans commerciaux, tout en r\u00e9duisant les co\u00fbts pour les \u00e9tablissements m\u00e9dicaux. \u00bb<\/p>\n<p>\u00c0 propos de QUBYX<\/p>\n<p>QUBYX est un fabricant de logiciels\/mat\u00e9riels offrant de nouvelles dimensions de la qualit\u00e9 d\u2019image dans l\u2019industrie de l\u2019imagerie m\u00e9dicale et le domaine de l\u2019\u00e9talonnage d\u2019\u00e9cran.<\/p>\n<p>Pour plus d\u2019informations, visitez : https:\/\/qubyx.com<\/p>\n<p>Contact presse :<\/p>\n<p>Marc Leppa CTO<\/p>\n<p>QUBYX Medical Solutions Inc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>QUBYX re\u00e7oit l\u2019autorisation FDA 510(k)&#8230;<\/p>\n","protected":false},"author":1,"featured_media":13736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1250],"tags":[],"class_list":["post-13733","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"acf":[],"_links":{"self":[{"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/posts\/13733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/comments?post=13733"}],"version-history":[{"count":0,"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/posts\/13733\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/media\/13736"}],"wp:attachment":[{"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/media?parent=13733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/categories?post=13733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qubyx.com\/fr\/wp-json\/wp\/v2\/tags?post=13733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}